The FDA ensures generic drug safety through strict approval processes, mandatory manufacturing inspections, and continuous post-market monitoring. Learn how bioequivalence, cGMP, and global oversight keep generics as safe as brand-name drugs.
Archive: 2025/11 - Page 2
China and India Manufacturing: Risks and FDA Monitoring in Pharmaceutical Supply Chains
Nov, 12 2025
China and India dominate global pharmaceutical manufacturing, but FDA monitoring reveals stark differences in drug safety. India leads in compliance; China leads in scale. Here's what it means for your medicine.
Proving bioequivalence for complex generics like inhalers, creams, and liposomal injections is far harder than for simple pills. Learn why traditional methods fail and how new science is changing the game.
Medications like SSRIs and diuretics can cause severe hyponatremia, leading to confusion, seizures, and even death if missed. Learn the warning signs, high-risk drugs, and how to prevent life-threatening complications.
Cipro (ciprofloxacin) is being phased out for many infections due to serious side effects. Learn which safer, equally effective antibiotics like nitrofurantoin, fosfomycin, and doxycycline are now preferred by doctors.